Toggle Main Menu Toggle Search

Open Access padlockePrints

Inherited resilience to clonal hematopoiesis by modifying stem cell RNA regulation

Lookup NU author(s): Dean Ranasinghe, Professor James AllanORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Somatic mutations increasing hematopoietic stem cell (HSC) fitness drive their expansion in clonal hematopoiesis (CH) and predispose to blood cancers. Population variation in the growth rate and potential of mutant clones suggests genetic factors may confer resilience against CH. Here, we identified a non-coding regulatory variant, rs17834140-T, that protects against CH and myeloid malignancies by selectively downregulating the RNA-binding protein MSI2 in HSCs. By modeling variant effects and mapping MSI2 binding targets, we uncovered an RNA network that maintains human HSCs and influences CH risk. rs17834140-T was associated with slower CH expansion, and stem cell MSI2 levels modified ASXL1-mutant HSC clonal dominance. These findings leverage natural resilience to illuminate post-transcriptional regulation in human HSCs, suggesting inhibition of MSI2 or its targets for blood cancer prevention.


Publication metadata

Author(s): Agarwal G, Antoszewski M, Xie X, Pershad Y, Arora UP, Poon C-L, Lyu P, Lee AJ, Guo C-J, Ye T, Norford LB, Neehus A-L, della Volpe L, Wahlster L, Ranasinghe D, Ho T-C, Barlowe T-S, Chow A, Schurer A, Taggart J, Durham BH, Abdel-Wahab O, McGraw KL, Allan JM, Soldatov R, Bick AG, Kharas MG, Sankaran VG

Publication type: Article

Publication status: Published

Journal: Science

Year: 2026

Volume: 391

Issue: 6780

Pages: 52-58

Print publication date: 01/01/2026

Online publication date: 01/01/2026

Acceptance date: 27/10/2025

Date deposited: 17/12/2025

ISSN (print): 0036-8075

ISSN (electronic): 1095-9203

Publisher: American Association for the Advancement of Science

URL: https://doi.org/10.1126/science.adx4174

DOI: 10.1126/science.adx4174

ePrints DOI: 10.57711/01p1-e344

Data Access Statement: All raw data for CD34+ MSI2-HyperTRIBE are available from the European Nucleotide Archive (ENA) under study accession no. ERP182264. All raw data for scRNA-seq (GSE291294) and related code are available in our GitHub repository (https://github.com/sankaranlab/chip_resilience) and Zenodo (67). Bulk RNA-seq (GSE291293) experiments are available in the Gene Expression Omnibus (GEO) repository. Bulk RNA-seq data of ASXL1 mutant or wild-type CD34+ cells from chronic myelomonocytic leukemia patients (GSE159543) were previously reported (48). No original code or materials were generated in this study.


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Alex’s Lemonade Stand Foundation
Break Through Cancer
Burroughs Wellcome Fund Career Award
American Society of Hematology
Bill and Melinda Gates Foundation
Blood Cancer United
Edward P. Evans Foundation
Howard Hughes Medical Institute
Mather’s Foundation
NIH grants R01 DK103794, R01 CA265726, R01 CA292941, R33 CA278393, and R01 HL146500
NIH grants DP5 OD029586, R01 AG088657, and R01 AG083736
NIH grants R01 DK101989, R01 CA193842, R01 HL135564, R01 CA274249, R01 CA186702, R01 CA283578, R01 CA225231, and P30 CA008748

Share